During the last session, Avenue Therapeutics Inc. (NASDAQ:ATXI)’s traded shares were 1.26 million, with the beta value of the company hitting -0.62. At the end
In today’s recent session, 2.32 million shares of the Avenue Therapeutics Inc. (NASDAQ:ATXI) have been traded, and its beta is -0.62. Most recently the company’s
Avenue Therapeutics Inc. (NASDAQ:ATXI)’s traded shares stood at 1.17 million during the last session, with the company’s beta value hitting -0.63. At the close of